Globe Life Inc.

NYSE:GL Lagerbericht

Marktkapitalisierung: US$12.0b

Globe Life Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Globe Life wird ein jährliches Gewinn- und Umsatzwachstum von 3.9% bzw. 5.6% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 8.1% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 16.2% betragen.

Wichtige Informationen

3.9%

Wachstumsrate der Gewinne

8.07%

EPS-Wachstumsrate

Insurance Gewinnwachstum2.0%
Wachstumsrate der Einnahmen5.6%
Zukünftige Eigenkapitalrendite16.24%
Analystenabdeckung

Good

Zuletzt aktualisiert04 May 2026

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Analyse-Update Apr 30

GL: Earnings Guidance And Buybacks Will Support Bullish Long Term Outlook

Analysts have kept their Globe Life price target steady at $199.00. This reflects only small adjustments to assumptions around revenue growth, profit margins, and future P/E that together leave their overall valuation view broadly unchanged.
Analyse-Update Apr 15

GL: Updated Capital Returns And Slightly Lower P/E Assumptions Will Guide Balanced Outlook

Analysts now see Globe Life's fair value at $146.00, down from $150.00. This reflects slightly adjusted assumptions for revenue growth, profit margin and future P/E in their updated models.
Analyse-Update Apr 01

GL: Higher P/E Assumptions And Capital Returns Will Shape Balanced Future Outcomes

Analysts have raised their price target on Globe Life to $150, up from $145. This change reflects updated assumptions for revenue growth, profit margins and future P/E multiples in their models.
Analyse-Update Mar 18

GL: Share Repurchases And Earnings Guidance Will Support Long-Term Upside

Analysts have adjusted their price target on Globe Life slightly higher to about $172 per share, reflecting updated assumptions for revenue growth, profit margin, discount rate, and future P/E. What's in the News Globe Life's board approved a quarterly dividend of $0.3300 per share, payable on May 1, 2026, to shareholders of record as of April 3, 2026 (Key Developments).
Seeking Alpha Mar 14

Globe Life: Undervalued Insurance For Your Portfolio

Summary Globe Life offers a compelling long-term dividend growth profile, despite its modest 0.8% yield, making it ideal for future-focused portfolios. GL’s affordable, sticky policies drive recurring revenue and organic growth, supported by a large underinsured market and expanding exclusive agent force. Trading at a 17% discount to a $171 fair value estimate, GL’s forward P/E of 9.2 is well below historical averages, positioning it for potential revaluation. With a low payout ratio and a 20-year dividend growth streak, GL targets double-digit annual dividend hikes and could deliver 11% annual total returns through 2031. Read the full article on Seeking Alpha
Analyse-Update Mar 04

GL: Future Earnings Outlook And Buybacks Will Support Bullish View

Analysts have maintained their Globe Life price target at $199, citing updated model inputs that reflect slightly different assumptions for the discount rate, revenue growth, profit margin, and future P/E, while still arriving at the same fair value estimate. What's in the News Globe Life's board approved a quarterly dividend of $0.33 per share, payable on May 1, 2026, to shareholders of record as of April 3, 2026 (company announcement).
Analyse-Update Feb 18

GL: Buybacks And Earnings Outlook Will Support Long-Term Upside

Analysts have adjusted their price target on Globe Life to $171.40 from $168.30. This reflects updated assumptions around revenue growth, profit margins, the discount rate, and future P/E expectations.
Analyse-Update Feb 04

GL: Higher Revenue Outlook And P/E Assumptions Will Shape Balanced Future Returns

Analysts have lifted their price target on Globe Life from US$111.00 to US$145.00, citing updated assumptions for discount rates, revenue growth, profit margins, and future P/E, which together support a higher valuation framework. Valuation Changes Fair Value: price target updated from US$111.00 to US$145.00, representing a sizeable upward reset in the valuation estimate.
Analyse-Update Jan 20

GL: Future Earnings Guidance And Buybacks Will Support Bullish View

Analysts have raised their price target on Globe Life from about $185 to $199, citing updated assumptions for fair value, discount rate, revenue growth, profit margins and future P/E. What's in the News Globe Life issued earnings guidance for 2025, projecting net operating income between $14.40 and $14.60 per diluted common share for the year ending December 31, 2025 (company guidance).
Analyse-Update Jan 06

GL: Steady Outlook And Ongoing Buybacks Will Support Long-Term Upside

Analysts have kept their price target for Globe Life broadly steady around $168.30, reflecting minor adjustments to assumptions for revenue growth, profit margin and future P/E that did not materially change their overall valuation view. What's in the News Globe Life issued earnings guidance for 2025, projecting net operating income between $14.40 and $14.60 per diluted share for the year ending December 31, 2025 (Key Developments).
Analyse-Update Dec 21

GL: Future Earnings Visibility And Buybacks Will Drive Long-Term Upside Potential

Analysts have raised their price target on Globe Life by approximately 1 dollar to reflect slightly higher modeled fair value, modestly improved margin and growth assumptions, and a marginally higher future P E multiple. What's in the News Issued earnings guidance for 2025, projecting net operating income of $14.40 to $14.60 per diluted share, signaling steady profit expectations (company guidance) Provided 2026 outlook with net operating income per share estimated between $14.60 and $15.30, suggesting continued earnings growth beyond next year (company guidance) Repurchased 1,274,691 shares between July 1 and September 30, 2025, equal to 1.57% of shares outstanding, for $172.95 million (buyback update) Reached 98.88% completion of a long running share repurchase program, totaling 143,773,686 shares bought back for $9,831.8 million since its announcement in August 2005 (buyback update) Valuation Changes Fair Value: increased slightly from $166.70 to $168.30 per share, reflecting a modestly higher modeled intrinsic value.
Analyse-Update Dec 07

GL: Expanding Earnings Guidance Will Drive Long-Term Upside Potential

Analysts have modestly raised their price target on Globe Life to approximately $166.70 per share from about $166.27. They cite slightly stronger projected profit margins, a marginally lower discount rate, and a small uptick in expected revenue growth and future earnings multiples.
Analyse-Update Nov 23

GL: Share Buyback Momentum And Earnings Guidance Will Drive Upside

Narrative Update on Globe Life: Analyst Price Target Adjustment Analysts have slightly lowered their fair value estimate for Globe Life by $0.18 to $166.27, citing marginal changes in projected revenue growth and profit margin expectations. What's in the News Globe Life Inc.
Analyse-Update Nov 08

GL: Share Repurchases And Earnings Guidance Will Drive Future Upside

Analysts have raised their price target for Globe Life slightly, increasing it from $166.27 to $166.45, based on adjusted expectations for revenue growth and profitability. What's in the News Globe Life Inc.
Analyse-Update Oct 25

Share Repurchases And Earnings Outlook Will Support Insurance Sector Expansion

Narrative Update: Globe Life Analyst Price Target Revision Analysts have slightly raised their fair value estimate for Globe Life, increasing the target from $165.73 to $166.27 per share. This change reflects improved expectations for profit margin and a stable growth outlook.
Analyse-Update Oct 11

Digital Underwriting And Agent Expansion Will Shape Insurance Future

Narrative Update: Globe Life Analyst Price Target Adjustment Analysts have raised their fair value estimate for Globe Life from $161.55 to $165.73, citing modest improvements in projected revenue growth and a slightly lower discount rate as key factors supporting the upward adjustment. What's in the News Globe Life Inc.
Analyse-Update Sep 27

Digital Underwriting And Agent Expansion Will Shape Insurance Future

Globe Life’s valuation metrics, including Future P/E and Discount Rate, remained essentially stable, resulting in only a marginal increase in the consensus Analyst Price Target from $160.18 to $161.55. What's in the News SEC concludes its investigation of Globe Life and does not intend to recommend an enforcement action.
Analyseartikel May 24

We Ran A Stock Scan For Earnings Growth And Globe Life (NYSE:GL) Passed With Ease

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Seeking Alpha Jan 23

Globe Life: A Stalwart That Can Balance Growth And Profitability

Summary Globe Life demonstrates steady EPS growth due to disciplined underwriting and cost efficiency. The company targets lower to middle-income families, maintaining stable annualized premiums and high underwriting margins. Globe Life's strong liquidity, high RBC ratio, and quality investment portfolio bolster its financial health. Shares are a buy with long-term price target of $180. Read the full article on Seeking Alpha
Seeking Alpha Sep 13

Globe Life: Boring, Which Is Good As A Policyholder-But Not As An Investor

Summary Globe Life's stable share price and low dividend yield make it a lackluster investment with limited growth potential and better alternatives available. The company’s business model and performance are respectable, but there are no significant catalysts for future gains. Despite a recent share buyback, Globe Life trails its peers and broader market indices in total return, making it a "pass" for investors. Read the full article on Seeking Alpha
User avatar
Neue Analyse Aug 25

Enhanced Credibility And Strategic Growth Initiatives Promise Bright Prospects

Audit Committee's findings boost Globe Life's credibility and investor confidence by clarifying financial integrity, influencing stock value positively.
Seeking Alpha Jun 24

Globe Life: A Small Bet That The Recent Controversy Will Blow Over

Summary Globe Life Inc. shares rebounded sharply after a short report by Fuzzy Panda, caused a short-lived over 50% drop in the stock. Despite the controversy, Globe Life reported strong 1Q24 financials, increased its FY24 outlook, and has seen some recent insider purchases in the shares. Allegations of fraud and misconduct did prompt the SEC to open an informal inquiry. Despite the rebound, the stock is still cheap on a P/E basis.  An analysis around Globe Life follows in the paragraphs below. Read the full article on Seeking Alpha
Seeking Alpha Apr 15

Globe Life: Betting On A Bounce To $80

Summary Globe Life experienced a significant drop in stock price after a report from Fuzzy Panda Research accused the company of unethical practices. The report compared Globe Life to other life insurance companies to build its negative narrative but did not assess industry standards or behaviors. In particular, Primerica. Fuzzy Panda held a $64.35 price target. GL has dropped below that mark. GL now has valuation metrics well below the industry average and significantly below PRI, it's most direct comparable as a life insurance company with an MLM sales structure. I believe that the stock price will bounce back to $80 or higher due to short sellers covering their positions and bullish investor speculation. Read the full article on Seeking Alpha

Gewinn- und Umsatzwachstumsprognosen

NYSE:GL - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/20287,1801,313N/AN/A3
12/31/20276,7881,240700N/A6
12/31/20266,4101,206650N/A6
3/31/20266,0741,177N/AN/AN/A
12/31/20255,9941,1611,2541,396N/A
9/30/20255,9411,1501,2461,383N/A
6/30/20255,8831,0661,3481,417N/A
3/31/20255,8421,0711,4101,484N/A
12/31/20245,7781,0711,3311,402N/A
9/30/20245,7271,0901,3881,457N/A
6/30/20245,6561,0441,3531,403N/A
3/31/20245,5421,0011,3051,356N/A
12/31/20235,4489711,4331,482N/A
9/30/20235,3679381,4181,463N/A
6/30/20235,2808721,4931,533N/A
3/31/20235,2458811,4731,502N/A
12/31/20225,2278941,3941,422N/A
9/30/20225,1898301,4011,428N/A
6/30/20225,1708281,4011,429N/A
3/31/20225,1498041,4331,463N/A
12/31/20215,1121,0311,3991,438N/A
9/30/20215,0447711,4141,458N/A
6/30/20214,9627711,3641,409N/A
3/31/20214,8717451,4571,505N/A
12/31/20204,7387321,4351,476N/A
9/30/20204,6467151,3711,412N/A
6/30/20204,5927271,4061,447N/A
3/31/20204,5417411,2401,284N/A
12/31/20194,528761N/A1,364N/A
9/30/20194,456739N/A1,371N/A
6/30/20194,398715N/A1,348N/A
3/31/20194,353713N/A1,319N/A
12/31/20184,304702N/A1,278N/A
9/30/20184,2961,564N/A1,281N/A
6/30/20184,2581,539N/A1,307N/A
3/31/20184,2021,495N/A1,351N/A
12/31/20174,1561,458N/A1,429N/A
9/30/20174,074556N/A1,513N/A
6/30/20174,018544N/A1,533N/A
3/31/20173,981543N/A1,519N/A
12/31/20163,935540N/A1,399N/A
9/30/20163,893534N/A1,362N/A
6/30/20163,851526N/A1,271N/A
3/31/20163,809519N/A1,181N/A
12/31/20153,766516N/A1,120N/A
9/30/20153,463529N/A950N/A
6/30/20153,490528N/A899N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: GLDas prognostizierte Gewinnwachstum (3.9% pro Jahr) liegt über der Sparquote (3.5%).

Ertrag vs. Markt: GLDie Erträge des Unternehmens (3.9% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (16.6% pro Jahr).

Hohe Wachstumserträge: GLDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: GLDie Einnahmen des Unternehmens (5.6% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (11.5% pro Jahr).

Hohe Wachstumseinnahmen: GLDie Einnahmen des Unternehmens (5.6% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.


Wachstumsprognosen für den Gewinn je Aktie


Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: GLDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (16.2%).


Wachstumsunternehmen entdecken

Unternehmensanalyse und Finanzdaten Status

DatenZuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse2026/05/07 19:03
Aktienkurs zum Tagesende2026/05/07 00:00
Gewinne2026/03/31
Jährliche Einnahmen2025/12/31

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

PaketDatenZeitrahmenBeispiel US-Quelle *
Finanzdaten des Unternehmens10 Jahre
  • Gewinn- und Verlustrechnung
  • Kapitalflussrechnung
  • Bilanz
Konsensschätzungen der Analysten+3 Jahre
  • Finanzielle Vorausschau
  • Kursziele der Analysten
Marktpreise30 Jahre
  • Aktienkurse
  • Dividenden, Splits und Aktionen
Eigentümerschaft10 Jahre
  • Top-Aktionäre
  • Insiderhandel
Verwaltung10 Jahre
  • Das Führungsteam
  • Direktorium
Wichtige Entwicklungen10 Jahre
  • Ankündigungen des Unternehmens

* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.

Analysemodell und Schneeflocke

Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.

Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.

Analysten-Quellen

Globe Life Inc. wird von 30 Analysten beobachtet. 8 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

AnalystEinrichtung
Jay GelbBarclays
Jack MattenBMO Capital Markets Equity Research
null nullBMO Capital Markets Equity Research